“…Given the major role of stress in exacerbating the symptoms of cognitive disorders, the current data also have relevance to the potential treatment of PFC deficits in mental illness. For example, deficits in dlPFC function are evident in schizophrenia ( Weinberger et al, 1986 ; Glantz and Lewis, 2000 ; Perlstein et al, 2001 ; Driesen et al, 2008 ; Barch and Ceaser, 2012 ), depression ( Holmes et al, 2019 ), bipolar disorder ( Blumberg et al, 1999 , 2003 ), PTSD ( Harnett et al, 2021 ; Aupperle et al, 2012 ; Holmes et al, 2018 ), substance abuse ( Smith et al, 2023 ), and Alzheimer's disease ( Hof and Morrison, 1991 ; Schroeter et al, 2012 ), all of which are worsened or caused by stress exposure ( Mazure, 1995 ; Sinha, 2007 ; Hart et al, 2017 ; Georgiades et al, 2023 ; Johansson et al, 2013 ; Nook et al, 2018 ). Treatment strategies for many of these disorders utilize repetitive transcranial magnetic stimulation to strengthen the left dlPFC and help restore top-down regulation e.g ( George et al, 2013 ; Gomis-Vicent et al, 2019 ), and thus, pharmacological strategies that restore PFC top-down regulation may also be helpful.…”